6.32 An osteoporosis drug, raloxifen, was tested against a placebo in a large double- blind experiment to see whether i...
6.32 An osteoporosis drug, raloxifen, was tested against a placebo in a large double- blind experiment to see whether it could prevent breast cancer in women as well as help osteoporosis. The average age of the women was 66, and the number of cases of breast cancer after four years of treatment is given in the table below. Use the binomial exact test (with technology) at the a 0.01 level of significance. Assume the random selection for treatment was done with T 2/3. Breast cancer No breast cancer Row total 5107 2537 5129 Raloxifen Placebo 2576 39 7705 61 7644 Column total
6.32 An osteoporosis drug, raloxifen, was tested against a placebo in a large double- blind experiment to see whether it could prevent breast cancer in women as well as help osteoporosis. The average age of the women was 66, and the number of cases of breast cancer after four years of treatment is given in the table below. Use the binomial exact test (with technology) at the a 0.01 level of significance. Assume the random selection for treatment was done with T 2/3. Breast cancer No breast cancer Row total 5107 2537 5129 Raloxifen Placebo 2576 39 7705 61 7644 Column total